From myositis to sarcoidosis: a rare autoimmune continuum

Read full text Summarise with VIRAT
Authors: Mert Can Ataca, Semih Gülle
Cited by: 0
References: 26

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Sarcoidosis is a multisystem granulomatous disease that may rarely coexist with idiopathic inflammatory myopathies. The overlap of sarcoidosis and idiopathic inflammatory myopathy is exceptional and poses diagnostic difficulties due to overlapping clinical and laboratory findings. Case presentation: A 35-year-old woman presented with progressive proximal muscle weakness and dyspnoea. Electromyography revealed primary muscle fibre involvement, and serum creatine kinase levels were markedly elevated. Initial muscle biopsy was nondiagnostic. Two years later, mediastinal lymph node biopsy showed nonnecrotising granulomatous inflammation, consistent with sarcoidosis. Sarcoidosis was initially managed conservatively due to the absence of organ-threatening involvement. Over time, progressive muscle weakness and respiratory symptoms recurred. Magnetic resonance imaging of the lower extremities revealed diffuse muscle oedema and enhancement consistent with inflammatory myopathy. Repeat electromyography findings supported idiopathic inflammatory myopathy. Laboratory tests showed antinuclear antibody 1:320 cytoplasmic homogeneous positivity, whereas myositis-specific antibodies were negative. The patient was diagnosed with sarcoidosis-idiopathic inflammatory myopathy overlap syndrome. She achieved complete clinical and biochemical remission following treatment with oral corticosteroids and azathioprine. Conclusion: The coexistence of sarcoidosis and idiopathic inflammatory myopathy is rare but should be considered in patients with granulomatous disease and progressive myopathy. Recognition of this overlap is essential for timely diagnosis and immunosuppressive therapy, which may lead to full recovery.

Fields of Study & Subjects

Inflammatory Myopathies and Dermatomyositis Sarcoidosis and Beryllium Toxicity Research Myasthenia Gravis and Thymoma

Publication details

Journal / source
EULAR Rheumatology Open
Volume
2
Issue
2
Pages
100149–100149
Publication date
27 March 2026
Language
EN